ATE88175T1 - Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik. - Google Patents

Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik.

Info

Publication number: ATE88175T1
Authority: AT; Austria
Prior art keywords: thioesters; lower alkyl; aromatic esters; human; hydrogen
Prior art date: 1988-01-20

Application number

AT89400162T

Other languages

English (en)

Inventor

Braham Villa Shroot

Jacques Eustache

Jean-Michel Bernardon

Original Assignee

Cird Galderma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-01-20

Filing date

1989-01-19

Publication date

1993-04-15

1989-01-19 Application filed by Cird Galderma filed Critical Cird Galderma

1993-04-15 Application granted granted Critical

1993-04-15 Publication of ATE88175T1 publication Critical patent/ATE88175T1/de

Links

150000007970 thio esters Chemical class 0.000 title abstract 4
239000002537 cosmetic Substances 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 6
229910052739 hydrogen Inorganic materials 0.000 abstract 5
239000001257 hydrogen Substances 0.000 abstract 5
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
125000003118 aryl group Chemical group 0.000 abstract 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
229910052799 carbon Inorganic materials 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
125000002950 monocyclic group Chemical group 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Chemical group 0.000 abstract 1
239000011593 sulfur Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

AT89400162T 1988-01-20 1989-01-19 Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik. ATE88175T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
LU87109A LU87109A1 (fr)	1988-01-20	1988-01-20	Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
EP89400162A EP0325540B1 (de)	1988-01-20	1989-01-19	Aromatische Ester und Thioester, ihr Herstellungsverfahren und ihre Anwendung in der Human- oder Tiermedizin und in der Kosmetik

Publications (1)

Publication Number	Publication Date
ATE88175T1 true ATE88175T1 (de)	1993-04-15

Family

ID=19731014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89400162T ATE88175T1 (de)	1988-01-20	1989-01-19	Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik.

Country Status (16)

Country	Link
US (1)	US4925658A (de)
EP (1)	EP0325540B1 (de)
JP (1)	JP2753300B2 (de)
AT (1)	ATE88175T1 (de)
AU (1)	AU613445B2 (de)
CA (1)	CA1338561C (de)
DE (1)	DE68905929T2 (de)
DK (1)	DK23189A (de)
ES (1)	ES2054038T3 (de)
FI (1)	FI93352C (de)
IE (1)	IE68445B1 (de)
LU (1)	LU87109A1 (de)
NO (1)	NO170009C (de)
NZ (1)	NZ227666A (de)
PT (1)	PT89480B (de)
ZA (1)	ZA89441B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4448006A (en)	1981-05-28	1984-05-15	Donn Incorporated	Grid ceiling structure and method of converting
FR2649977B1 (fr) *	1989-07-18	1991-10-04	Cird	Esters bi-aromatiques, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2728166A1 (fr)	1994-12-19	1996-06-21	Oreal	Composition topique contenant un antagoniste de substance p
FR2729854A1 (fr)	1995-01-26	1996-08-02	Oreal	Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
FR2741878B1 (fr) *	1995-12-01	1998-01-09	Cird Galderma	Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US20050113283A1 (en) *	2002-01-18	2005-05-26	David Solow-Cordero	Methods of treating conditions associated with an EDG-4 receptor
EP2377532A1 (de)	2004-08-18	2011-10-19	Ace ApS	Kosmetische und pharmazeutische Zusammensetzungen mit ACE-Hemmern und/oder Angiotensin-II-Rezeptorantagonisten zur Behandlung von Hauterkrankungen
US8158136B2 (en)	2004-08-18	2012-04-17	L'oréal	Emulsification system for use in cosmetics
MX2007004135A (es) *	2004-10-04	2007-06-15	Oreal	Composicion cosmetica y/o dermatologica para pieles sensibles.
FR2889057B1 (fr) *	2005-08-01	2008-07-18	Oreal	Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2889808B1 (fr)	2005-08-17	2011-07-22	Oreal	Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
FR2910321B1 (fr)	2006-12-21	2009-07-10	Galderma Res & Dev S N C Snc	Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr)	2006-12-21	2009-02-13	Galderma Res & Dev S N C Snc	Emulsion comprenant au moins un retinoide et du peroxyde de benzole
CA2678496A1 (en)	2007-02-20	2008-08-28	Galderma Research & Development	A method for delivery of a therapeutic substance into the skin
FR2912651A1 (fr)	2007-02-21	2008-08-22	Oreal	Emulsion e/h pour le soin de la peau.
FR2912917B1 (fr)	2007-02-26	2012-05-18	Oreal	Milieu conditionne et ses utilisations
FR2918886B1 (fr)	2007-07-17	2010-01-08	Oreal	Utilisation d'au moins un extrait bacterien cultive sur eau thermale pour le traitement des peaux, muqueuses et cuirs chevelus sensibles
FR2919501B1 (fr) *	2007-08-02	2010-12-31	Oreal	Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920304B1 (fr)	2007-09-04	2010-06-25	Oreal	Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
CA2697735C (en) *	2007-09-04	2014-02-18	L'oreal	Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
FR2920305B1 (fr)	2007-09-04	2010-07-30	Oreal	Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2928542B1 (fr)	2008-03-13	2011-12-09	Oreal	Procede de maquillage des levres
FR2931661B1 (fr)	2008-05-30	2010-07-30	Galderma Res & Dev	Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
FR2940907B1 (fr)	2009-01-15	2011-03-04	Oreal	Composition cosmetique ou dermatologique, comprenant un retinoide, un compose non phosphate a base d'adenosine et un polymere semi-cristallin
FR2942719B1 (fr) *	2009-03-04	2011-08-19	Oreal	Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2011010075A1 (fr)	2009-07-24	2011-01-27	L'oreal	Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2953716B1 (fr)	2009-12-16	2015-03-27	Oreal	Kit de formulation d'un produit cosmetique
FR2968952A1 (fr)	2010-12-17	2012-06-22	Oreal	Ester d'acide amine n-acyle a titre d'agent apaisant
FR2981272A1 (fr)	2011-10-14	2013-04-19	Inneov Lab	Utilisation d'une composition orale comprenant un melange d'au moins un polyphenol, de zinc, et de vitamine c.
EP2836187B1 (de)	2012-04-11	2021-12-08	L'Oréal	Selbsttragende kosmetische folie
FR2996135A1 (fr)	2012-09-28	2014-04-04	Inneov Lab	Composition orale pour renforcer la tolerance cutanee suite a une administration topique d'un compose retinoide.
EP2789369B1 (de)	2013-04-14	2018-06-06	Symrise AG	Eine Zubereitung zur Aufhellung von Haut und Haaren
EP2842607B1 (de)	2013-09-02	2018-05-30	Symrise AG	Eine Mischung zur Aufhellung von Haut und/oder Haaren
US10765621B2 (en)	2013-09-22	2020-09-08	Symrise Ag	Extracts of halimione portulacoides and their application
EP2853254B1 (de)	2013-09-26	2017-11-08	Symrise AG	Kosmetische Zusammensetzung zur Aufhellung von Haut und/oder Haaren
EP2859883B1 (de)	2013-10-13	2019-05-15	Symrise AG	Mischungen von Aktivstoffen enthaltend acylierte Oligopeptide und Troxerutin
EP3062766A1 (de)	2013-10-29	2016-09-07	L'Oreal, S.A.	Verwendung von mono-ornithin-ketoglutarat (mokg)
EP2979682B1 (de)	2014-07-30	2018-09-05	Symrise AG	Parfümzubereitung
EP3023090B1 (de)	2014-11-21	2019-08-07	Symrise AG	Zubereitungen
EP3045161B1 (de)	2015-01-18	2026-03-25	Symrise AG	Verwendung von Wirkstoffgemischen aus 1,2-Hexandiol und 1,2-Octandiol in kosmetischen, pharmazeutischen oder dermatologischen Emulsionen
ES2933563T3 (es)	2015-04-16	2023-02-10	Symrise Ag	Uso de una composición de liposoma
CN107530273B (zh)	2015-04-28	2021-07-09	库泰克有限责任公司	含有缬草提取物的组合物
EP3097905B1 (de)	2015-05-28	2020-11-04	Symrise AG	Kosmetische zubereitungen
EP3108941B1 (de)	2015-06-23	2018-05-09	Symrise AG	Zubereitungen enthaltend polyalkylenglykol-derivate
EP3347445B1 (de)	2015-09-08	2024-10-30	Symrise AG	Duftstoffgemische
US10639251B2 (en)	2015-10-28	2020-05-05	Symrise Ag	Method for inhibiting or masking fishy odours
US12053537B2 (en)	2015-11-15	2024-08-06	Symrise Ag	Reduction of stinging sensation on skin
WO2017097434A1 (en)	2015-12-06	2017-06-15	Symrise Ag	A fragrance composition
CN109862875A (zh)	2016-03-30	2019-06-07	西姆莱斯股份公司	一种活性混合物
EP4603149A3 (de)	2016-08-20	2025-12-24	Symrise AG	Konservierende mischung
US11123272B2 (en)	2016-12-02	2021-09-21	Symrise Ag	Cosmetic blends
FR3061002B1 (fr)	2016-12-23	2019-05-24	L'oreal	Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside
IT201700090929A1 (it)	2017-08-07	2019-02-07	Cutech S R L	Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea.
DE202017007679U1 (de)	2017-08-09	2024-03-15	Symrise Ag	1,2-Alkandiole
US20210085579A1 (en)	2017-08-09	2021-03-25	Symrise Ag	1,2-alkanediols and a process for their production
KR102562938B1 (ko)	2018-03-08	2023-08-02	시므라이즈 아게	인간 스킨 및/또는 헤어의 트리트먼트를 위한 단백질 추출물을 포함하는 혼합물들
KR102837846B1 (ko)	2018-09-20	2025-07-23	시므라이즈 아게	무취 1,2-펜탄디올을 포함하는 조성물
EP3938055A1 (de)	2019-03-12	2022-01-19	Symrise AG	Antimikrobielle mischung
CN115297833B (zh)	2020-03-31	2024-07-09	莱雅公司	呈凝胶形式的化妆品组合物
PL4096618T3 (pl)	2020-12-09	2025-08-11	Symrise Ag	Mieszanina zawierająca 1,2-alkanodiole
EP4370092A2 (de)	2021-07-16	2024-05-22	L'oreal	Nicht-therapeutisches kosmetisches verfahren zur verminderung von falten auf der hautoberfläche
FR3126311B1 (fr)	2021-08-27	2024-12-20	Oreal	Procede cosmetique non therapeutique pour reduire les rides sur une surface de la peau, kit pour la mise en œuvre du procede, et procede d’utilisation d’un kit
EP4452190A1 (de)	2021-12-20	2024-10-30	L'oreal	Stabile zusammensetzung mit retinoid und ascorbinsäureverbindung
FR3131837B1 (fr)	2022-01-19	2024-10-04	Oreal	Composition stable comprenant un rétinoïde et un composé acide ascorbique
WO2023120259A1 (en)	2021-12-20	2023-06-29	Oreal	Stable composition comprising retinoid
FR3131845B1 (fr)	2022-01-19	2024-11-01	Oreal	Composition stable comprenant un rétinoïde
WO2024045049A1 (en)	2022-08-31	2024-03-07	L'oreal	Composition for caring for keratin materials and mask containing the same
WO2024135577A1 (en)	2022-12-23	2024-06-27	L'oreal	Stable dispersion composition comprising retinoid
FR3145278B1 (fr)	2023-01-30	2026-04-10	Oreal	Composition de dispersion stable comprenant un rétinoïde
FR3148912B1 (fr)	2023-05-24	2026-02-20	Oreal	Composition comprenant des polymères cationiques et anioniques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1290848A (de) *	1968-11-11	1972-09-27
CH586728A5 (de) *	1972-12-26	1977-04-15	Ciba Geigy Ag
US4051104A (en) *	1972-12-26	1977-09-27	Ciba-Geigy Corporation	Benzoyloxybenzoates and compositions stabilized therewith

1988
- 1988-01-20 LU LU87109A patent/LU87109A1/fr unknown
1989
- 1989-01-19 ES ES89400162T patent/ES2054038T3/es not_active Expired - Lifetime
- 1989-01-19 AU AU28608/89A patent/AU613445B2/en not_active Ceased
- 1989-01-19 AT AT89400162T patent/ATE88175T1/de active
- 1989-01-19 PT PT89480A patent/PT89480B/pt not_active IP Right Cessation
- 1989-01-19 DK DK023189A patent/DK23189A/da not_active Application Discontinuation
- 1989-01-19 CA CA000588639A patent/CA1338561C/fr not_active Expired - Fee Related
- 1989-01-19 IE IE15289A patent/IE68445B1/en not_active IP Right Cessation
- 1989-01-19 DE DE8989400162T patent/DE68905929T2/de not_active Expired - Fee Related
- 1989-01-19 US US07/298,982 patent/US4925658A/en not_active Expired - Lifetime
- 1989-01-19 NO NO890252A patent/NO170009C/no unknown
- 1989-01-19 FI FI890291A patent/FI93352C/fi not_active IP Right Cessation
- 1989-01-19 ZA ZA89441A patent/ZA89441B/xx unknown
- 1989-01-19 JP JP1008757A patent/JP2753300B2/ja not_active Expired - Fee Related
- 1989-01-19 EP EP89400162A patent/EP0325540B1/de not_active Expired - Lifetime
- 1989-01-19 NZ NZ227666A patent/NZ227666A/en unknown

Also Published As

Publication number	Publication date
NO170009C (no)	1992-09-02
DK23189A (da)	1989-07-21
NZ227666A (en)	1991-04-26
LU87109A1 (fr)	1989-08-30
FI93352C (fi)	1995-03-27
FI93352B (fi)	1994-12-15
DE68905929T2 (de)	1993-07-22
ES2054038T3 (es)	1994-08-01
CA1338561C (fr)	1996-08-27
ZA89441B (en)	1989-10-25
FI890291A7 (fi)	1989-07-21
NO890252L (no)	1989-07-21
JP2753300B2 (ja)	1998-05-18
PT89480B (pt)	1994-08-31
IE890152L (en)	1989-07-20
DE68905929D1 (de)	1993-05-19
DK23189D0 (da)	1989-01-19
US4925658A (en)	1990-05-15
NO890252D0 (no)	1989-01-19
PT89480A (pt)	1989-10-04
IE68445B1 (en)	1996-06-12
EP0325540A1 (de)	1989-07-26
JPH029841A (ja)	1990-01-12
FI890291A0 (fi)	1989-01-19
AU613445B2 (en)	1991-08-01
AU2860889A (en)	1989-07-20
EP0325540B1 (de)	1993-04-14
NO170009B (no)	1992-05-25

Publication	Publication Date	Title
DE68905929D1 (de)	1993-05-19	Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik.
NZ240189A (en)	1993-08-26	Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof
SE8800949D0 (sv)	1988-03-16	Aromatiska karboxylsyraderivat och anvendning av dessa som mellanprodukter for framstellning av aromatiska heterocykliska derivat med terapeutiska och kosmetiska egenskaper
ES2002727A6 (es)	1988-10-01	Procedimiento de preparacion de derivados aromaticos policiclicos
AU613618B2 (en)	1991-08-08	Polycyclic heterocyclic compounds, a process for their preparation and their use in human and veterinary medicine
NO302523B1 (no)	1998-03-16	Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
ATE268587T1 (de)	2004-06-15	Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
DK0661260T3 (da)	1997-07-28	Hidtil ukendte biaromatiske forbindelser afledt af amider, farmaceutiske og kosmetiske præparater,der indeholder dem, og deres anvendelser
DE69001515D1 (de)	1993-06-09	Urethan-derivate, ihre herstellung und verwendung als hautbefeuchtendes mittel in kosmetischen und pharmazeutischen zubereitungen zur behandlung trockener haut.
DK0658553T3 (da)	1999-07-19	Hidtil ukendte polycykliske aromatiske forbindelser, farmaceutiske præparater og kosmetiske sammensætninger indeholdende di
KR910700230A (ko)	1991-03-14	신규 히드록실아민 유도체
ZA893474B (en)	1991-01-30	Sulphur-containing eicosanoides and their application in pharmacy and in cosmetics
FI853233L (fi)	1986-02-26	1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
DE58904337D1 (de)	1993-06-17	Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
DE69015787D1 (de)	1995-02-16	Thiophenderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE110568T1 (de)	1994-09-15	Pharmazeutisches präparat zur behandlung des katarakts.
ATE162195T1 (de)	1998-01-15	4-hydroxy-phenyl-beta-d-glukose-monoester, verfahren zur ihrer herstellung und ihre verwendung in der kosmetik, der pharmazie, als zahnpflegemitteln und lebensmitteln
ATE66920T1 (de)	1991-09-15	Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
ATE181503T1 (de)	1999-07-15	Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
DE69008762D1 (de)	1994-06-16	Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
DE3866603D1 (de)	1992-01-16	1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.
ES2072005T3 (es)	1995-07-01	Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel.
DE69008761D1 (de)	1994-06-16	Retinsäureester von D-Desosamin, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
IT1215578B (it)	1990-02-14	Derivati di 1-arilsolfonil1,5-diidro 2h-pirrol 2-one, loro procedimento di preparazione e loro applicazione come sostanze medicinali.
JPS6426553A (en)	1989-01-27	Novel derivative of 1-benzyl-2-oxo-5-alkoxy- pyrrolidine, manufacture, use as drug and composition